pipette
ENEnglish

Modeling human embryonic adrenogenesis in pluripotentstem cell-derived corticomedullar-like assembloids

F. Saleh, F. R. James, D. Rovello, M. McIlwain, A. Xiao, C. Powers, N. Reichman, M. Gonzalez, B. Caiazza, M. Kahn, Z.-Y. Liu, P. Nehru, C. Torres, T. Zhou, L. Francoeur, L. Man, Z. Rosenwaks, D. J. James

PreprintAfirmaciones fuertes, leer con cuidadoUso en el mundo real

En palabras de los autores

During embryogenesis, the cortical and medullary compartments of the adrenal gland emerge from two distinct sources: intermediate mesoderm-derived steroidogenic progenitors that comprise the cortex, and migratory neural crest-derived catecholaminergic progenitors that give rise to the medulla. The distinct cellular origins and paracrine signaling environments that foster induction, differentiation, and/or migration of cortical and medullary layers present challenges to recapitulating their co-emergence and incorporation in a human pluripotent stem cell (hPSC) based system. To address this, we developed an approach for modeling the adreno-gonadal primordium (AGP) in compound organoids that are organized along a gradient of NR5A1 expression and which unexpectedly incorporate SOX10-expressing Schwann cell precursors that ultimately generate chromaffin cells. Deconstruction of paracrine signaling within AGP-like organoids (AGPLOs) identified a fibroblast growth factor 9 (FGF9)-driven mechanism that expands bridge cell-like chromaffin progenitors and correlates to paracrine signaling cues encountered by physiological correlates along their migration corridor to the cortex in vivo. Combination of NR5A1-expressing cells with chromaffin cell clusters generated corticomedullar-like assembloids (CMLAs) that generated steroids and catecholamines and were responsive to adrenocorticotropic hormone. This work establishes a platform for modeling the reciprocal signaling relationships that drive adrenal gland development and function in health and disease and provides an approach for generating hPSC-derived adrenal cells/tissues that can be applied therapeutically.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 25 de septiembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.09.23.753945